AMN Healthcare Reports Strong Financial Growth in Second Quarter of 2026
AMN Healthcare Reports Strong Financial Growth in Second Quarter of 2026
On August 6, 2026, AMN Healthcare Services, Inc. (NYSE: AMN), a leading provider in total talent solutions for healthcare organizations, released its impressive financial results for the second quarter of 2026. The company’s consolidated revenue reached an exceptional $673 million, representing a 2% increase compared to the same quarter last year. The results reflect the growing demand for healthcare staffing solutions as the country continues to navigate the evolving healthcare landscape.
Financial Highlights
AMN's financial performance for Q2 2026 revealed several notable achievements:
- - Adjusted EBITDA increased 26% year-over-year, reaching $73 million.
- - The GAAP income per share was recorded at $0.53, compared to a loss in the previous year.
- - Adjusted diluted EPS soared to $0.77, reflecting a significant 158% increase.
The company attributed its success to strong growth in its travel nurse and allied worker segments, along with successful acquisitions that bolstered their operational capabilities. With a net income of $21 million, AMN demonstrated a remarkable recovery from the previous year's loss of $116 million.
Segment Performance
The revenue breakdown by segment illustrates AMN Healthcare's diverse offerings:
- - Nurse and Allied Solutions experienced an 11% increase, totaling $422 million. Travel nurse staffing also saw a year-over-year rise of 10%.
- - The Physician and Leadership Solutions segment reported $165 million in revenue despite a slight decline of 6% year-over-year. Notably, the executive search and physician placement services delivered a solid 27% growth.
- - In the Technology and Workforce Solutions segment, revenue stood at $87 million, maintaining stability amid broader market fluctuations.
Operational Improvements
AMN Healthcare’s operational edge is highlighted by a gross margin of 30.6%, a notable improvement driven by reserve releases and billing true-ups related to previous labor disruption events. The company’s focus on controlled SG&A expenses allowed them to decrease costs from $155 million last year to $147 million this quarter.
CEO Cary Grace remarked, "We are pleased with our team's performance. The year-over-year growth showcases our commitment to healthcare professionals and clients. Solutions like our managed services and search practices continue to solidify our market presence."
Looking Ahead: Q3 2026 Guidance
For the upcoming third quarter, AMN's guidance projects a consolidated revenue between $640 and $655 million, with nurse and allied solutions expected to increase by 9-11% year-over-year. However, the physician and leadership solutions segment anticipates a decline of 5-7%, indicating a mixed outlook across their services.
AMN remains dedicated to expanding its technology-driven offerings while deepening client relationships. The integration of Jaide Health and enhanced AI capabilities in their services indicates an innovative trajectory that aims to optimize healthcare delivery.
Conclusion
Overall, AMN Healthcare’s financial results for the second quarter of 2026 underscore the company's resilience and adaptability in a challenging market. Their ability to deliver high-quality healthcare staffing solutions positions them well for future growth as healthcare demands continue to evolve. Investors and stakeholders will be keenly observing how AMN navigates the complexities of the healthcare landscape amid the ongoing challenges of talent acquisition and market dynamics.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.